The Principles of Democracy and Its Role in Modern Governance…

Question

Tinni AnnieBegginer

Asked: July 20, 20242024-07-20T00:51:34+05:30 2024-07-20T00:51:34+05:30In: Bio-technology, Science & Technology, Science & Technology Since Independence

What are the challenges in scaling up the production of biopharmaceuticals using microbial cell factories?

What are the challenges in scaling up the production of biopharmaceuticals using microbial cell factories?

You must login to add an answer.

or use

Need An Account,

latha karunakaran · Answer 1 · 2024-07-20T04:33:43+05:30

Scaling up production of biopharmaceuticals using microbial cell factories faces numerous challenges ;

Yield optimization is critical, requiring genetic and metabolic engineering to enhance productivity. Maintaining product quality and consistency at larger scales demands stringent control over fermentation conditions and purification processes, addressing issues like contamination and variability.
Upstream challenges include optimizing nutrient supply, oxygenation, and scaling fermentation parameters to maintain optimal growth.
Downstream, efficient purification methods are crucial to achieve high purity and concentration of the final product.
Cost considerations are significant, encompassing equipment, raw materials, energy, and labor costs, impacting economic feasibility.
Regulatory compliance with GMP standards is essential, necessitating rigorous process validation and quality assurance.
Technological limitations may require adaptation or development of scalable bioprocessing technologies.
Managing environmental impacts and risks associated with scale-up, such as environmental footprint and supply chain disruptions, requires strategic planning.
Overall, successful scaling involves interdisciplinary expertise in microbiology, bioprocess engineering, regulatory affairs, and economics to overcome these challenges and meet demand for biopharmaceuticals effectively.

latha karunakaran · Answer 2 · 2024-07-20T04:34:04+05:30

Scaling up production of biopharmaceuticals using microbial cell factories faces numerous challenges ;

Yield optimization is critical, requiring genetic and metabolic engineering to enhance productivity. Maintaining product quality and consistency at larger scales demands stringent control over fermentation conditions and purification processes, addressing issues like contamination and variability.
Upstream challenges include optimizing nutrient supply, oxygenation, and scaling fermentation parameters to maintain optimal growth.
Downstream, efficient purification methods are crucial to achieve high purity and concentration of the final product.
Cost considerations are significant, encompassing equipment, raw materials, energy, and labor costs, impacting economic feasibility.
Regulatory compliance with GMP standards is essential, necessitating rigorous process validation and quality assurance.
Technological limitations may require adaptation or development of scalable bioprocessing technologies.
Managing environmental impacts and risks associated with scale-up, such as environmental footprint and supply chain disruptions, requires strategic planning.
Overall, successful scaling involves interdisciplinary expertise in microbiology, bioprocess engineering, regulatory affairs, and economics to overcome these challenges and meet demand for biopharmaceuticals effectively.